What is Zileuton used for?

Zileuton: A Comprehensive Overview

Introduction to Zileuton

Zileuton is a pharmaceutical drug primarily used to manage and treat asthma. It is marketed under the trade name Zyflo and Zyflo CR (for the controlled-release formulation). Developed in the late 20th century, Zileuton stands out due to its unique mechanism of action targeting the 5-lipoxygenase enzyme, a critical component in the biosynthesis of leukotrienes. Leukotrienes are lipid compounds that play a significant role in inflammation and bronchoconstriction, making them pivotal targets in asthma treatment.

Research institutions, including Abbott Laboratories and subsequent entities, have contributed extensively to the development and clinical trials of Zileuton. Classified as a leukotriene synthesis inhibitor, Zileuton is designed for the prophylaxis and chronic treatment of asthma in adults and children over the age of 12. The drug has undergone rigorous clinical testing and has been approved by regulatory bodies such as the FDA for its efficacy in improving lung function and reducing asthma symptoms.

 

Researching Zileuton beyond the basics?

Synapse Hiro LS Researcher, the Synapse AI Insight Engine, is built to accelerate biopharma decisions. Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence. Explore Zileuton with Hiro LS Researcher →

Zileuton Mechanism of Action

The therapeutic efficacy of Zileuton lies in its distinctive ability to inhibit the 5-lipoxygenase enzyme. This enzyme is responsible for the conversion of arachidonic acid to leukotrienes, which are potent mediators of inflammation and bronchoconstriction. By inhibiting 5-lipoxygenase, Zileuton effectively reduces the production of leukotrienes.

Leukotrienes are known to contribute significantly to the pathophysiology of asthma by causing the bronchial tubes to constrict, increasing mucus production, and promoting inflammation within the airways. By curtailing leukotriene synthesis, Zileuton helps to open the bronchial tubes, decreasing mucus production, and attenuating inflammatory responses. This results in better airflow, reduced asthma attacks, and overall improved respiratory function.

How to Use Zileuton

Zileuton is administered orally, and it is available in two formulations: immediate-release tablets (Zyflo) and controlled-release tablets (Zyflo CR). The immediate-release formulation is typically taken four times a day, while the controlled-release version is taken twice daily. It is essential to follow the prescribing physician's instructions closely regarding dosage and timing to achieve optimal therapeutic outcomes.

The onset of action for Zileuton is relatively rapid, with improvements in lung function often observed within a few hours to a few days of initiating treatment. However, it may take several weeks of consistent use to observe the full benefits. Patients are advised to take Zileuton with food to enhance absorption and minimize gastrointestinal discomfort.

For individuals with chronic asthma, it is crucial to maintain a consistent medication schedule, even when symptoms are absent, as Zileuton is designed to manage and prevent chronic symptoms rather than provide immediate relief during acute asthma attacks.

What is Zileuton Side Effects

While Zileuton is generally well-tolerated, it may cause side effects in some individuals. Common side effects include headache, dyspepsia, nausea, and diarrhea. Some patients may also experience upper respiratory tract infections, sinusitis, and throat pain. 

More severe side effects, though rare, include liver dysfunction, as indicated by elevated liver enzymes. It is imperative for patients to undergo regular liver function tests during treatment, especially during the initial months. Symptoms of liver dysfunction may include jaundice, dark urine, fatigue, and abdominal pain. If any of these symptoms occur, patients should contact their healthcare provider immediately.

There are several contraindications for the use of Zileuton. It is contraindicated in individuals with active liver disease or persistent elevations in liver enzymes. Additionally, it should be used with caution in patients with a history of liver conditions. Zileuton is not recommended for use during acute asthma attacks or in patients younger than 12 years old.

What Other Drugs Will Affect Zileuton

Zileuton may interact with other medications, potentially altering its efficacy or increasing the risk of adverse effects. Notable drug interactions include:

1. **Theophylline**: Zileuton can increase the serum concentration of theophylline, a bronchodilator used in asthma treatment. This interaction may necessitate the adjustment of theophylline dosage to prevent toxicity.

2. **Warfarin**: Concomitant use of Zileuton and warfarin, an anticoagulant, can enhance the anticoagulant effect, increasing the risk of bleeding. Close monitoring of prothrombin time or INR is advised.

3. **Propranolol**: Zileuton may elevate the levels of propranolol, a beta-blocker used in treating hypertension and arrhythmias. Dosage adjustments of propranolol may be required to avoid adverse cardiovascular effects.

4. **Other Hepatotoxic Drugs**: Caution is warranted when Zileuton is prescribed alongside other drugs known to cause liver toxicity, such as methotrexate and isoniazid. The combined hepatotoxic potential could exacerbate liver damage.

5. **Alcohol**: Patients are advised to limit or avoid alcohol consumption during Zileuton therapy due to the increased risk of liver damage.

In conclusion, Zileuton is a potent and effective medication for managing chronic asthma through its inhibition of leukotriene synthesis. While it offers significant benefits in improving respiratory function and reducing asthma symptoms, it requires careful monitoring for potential side effects and drug interactions. Patients should maintain open communication with their healthcare providers to ensure safe and effective use of Zileuton in their asthma management regimen.

Continue your Zileuton research with Synapse Hiro LS Researcher

This article provides an overview. For a broader research view, use Synapse Hiro LS Researcher—the Synapse AI Insight Engine—to search across drugs, targets, indications, clinical trials, literature, organizations, news, deals, and competitor signals. Ask any biopharma research question in natural language.

Questions to explore:

• What approved and investigational uses have been reported for Zileuton?
• What is the mechanism of action of Zileuton, and which targets or pathways are involved?
• Which clinical trials are evaluating Zileuton, and what outcomes have been reported?
• What patents, publications, and regulatory sources provide the latest evidence on Zileuton?

Ask Synapse Hiro LS Researcher →

AI may make mistakes. Check important info.